August 9, 2022 Life Science Tools Product Launch

QIAGEN launches new solutions that significantly accelerate DNA variant detection and RNA sequencing of low-input samples

August 9, 2022 QIAseq Targeted DNA Pro Panels halve library preparation time for sequencing samples New low-input kit for RNA sequencing further expands QIAGEN’s universal NGS portfolio and reduces disposable plastics use by 90%  Four million samples have been processed by growing range of QIAseq NGS panels running on any sequencer Hilden, Germany, and Germantown,... Read more

August 9, 2022 M&A, Partnerships Process Analytical Instr.

908 Devices Acquires TRACE Analytics, Enabling On-line Bioanalytics

08.09.22 BOSTON–(BUSINESS WIRE)–908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announces that it has completed the acquisition of privately-held TRACE Analytics GmbH, based in Braunschweig, Germany, a provider of on-line analysis and sampling systems for biotech applications. 908 Devices expects the acquired technology to... Read more

August 9, 2022 M&A, Partnerships

GE Healthcare in collaboration with Nex Cubed select six digital health start-ups for inaugural Edison Accelerator in Canada

Toronto, Canada – August 9 – Six digital health start-ups from five countries have officially become the first cohort of the Edison Accelerator in Canada – a program designed by GE Healthcare and delivered in collaboration with Nex Cubed to accelerate, validate, and scale innovative solutions that address important challenges in the healthcare sector. The... Read more

August 8, 2022 Lab Equipment M&A, Partnerships

Azenta Announces Agreement to Acquire B Medical Systems

CHELMSFORD, Mass., Aug. 8, 2022 /PRNewswire/ — Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered into a definitive agreement to acquire B Medical Systems S.á r.l and its subsidiaries (“B Medical”), a market leader in temperature-controlled storage and transportation solutions that enables the delivery of life-saving treatments across the globe. The cash purchase price to... Read more

August 3, 2022 Clinical Research/Diagn. Life Science Tools M&A, Partnerships

Bio-Rad Acquires Curiosity Diagnostics

August 03, 2022 HERCULES, Calif.–(BUSINESS WIRE)– Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, announced today that it has reached an agreement to acquire all of the outstanding shares of Curiosity Diagnostics, Sp. Z. o. o. from Scope Fluidics, S.A. (WSE NewConnect: SCP), a Warsaw, Poland,... Read more